J G den Hollander
Overview
Explore the profile of J G den Hollander including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weijsenfeld A, Smit C, Cohen S, Wit F, Mutschelknauss M, van der Knaap L, et al.
Clin Infect Dis
. 2016 Jul;
63(8):1105-1112.
PMID: 27439528
Background: As a result of effective combination antiretroviral therapy (cART) and advanced supportive healthcare, a growing number of human immunodeficiency virus (HIV)-infected children survive into adulthood. The period of transition...
2.
van Nispen tot Pannerden C, Van Gompel F, Rijnders B, Caumes E, den Hollander J
Neth J Med
. 2007 May;
65(5):188-90.
PMID: 17519515
A 33-year-old Dutch woman developed itchy skin lesions during a beach holiday in Thailand. She was treated for various diagnoses, without success. Finally she was successfully treated for a clinically...
3.
den Hollander J, Gotz H
Ned Tijdschr Geneeskd
. 2005 Dec;
149(48):2702.
PMID: 16358625
No abstract available.
4.
Ruys T, den Hollander J, Beld M, van der Ende M, van der Meer J
Ned Tijdschr Geneeskd
. 2004 Dec;
148(47):2309-12.
PMID: 15587046
An acute hepatitis C infection was diagnosed in three HIV-positive gay men, aged 43, 48 and 30 years, respectively. In all three, unprotected sexual intercourse and fisting was a universal...
5.
den Hollander J, Swaak A
Ann Rheum Dis
. 2002 Jan;
61(1):88-9.
PMID: 11779772
No abstract available.
6.
Schiffelers R, Storm G, ten Kate M, den Hollander J, Verbrugh H
J Pharmacol Exp Ther
. 2001 Jun;
298(1):369-75.
PMID: 11408564
Antimicrobial agents may interact synergistically. But to ensure synergy in vivo, the drugs should both be present at the site of infection at sufficiently high concentrations for an adequate period...
7.
den Hollander J, Mouton J
Ned Tijdschr Geneeskd
. 1998 Sep;
142(26):1520.
PMID: 9752073
No abstract available.
8.
den Hollander J, Fuursted K, Verbrugh H, Mouton J
Antimicrob Agents Chemother
. 1998 Apr;
42(4):749-54.
PMID: 9559777
The influence of half-life on the postantibiotic effect (PAE) of tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus was investigated during one dosing interval. Tobramycin half-lives of 0.5 to 2.5 h...
9.
den Hollander J, Mouton J, Verbrugh H
Antimicrob Agents Chemother
. 1998 Apr;
42(4):744-8.
PMID: 9559776
Combination therapy with antimicrobial agents can be used against bacteria that have reduced susceptibilities to single agents. We studied various tobramycin and ceftazidime dosing regimens against four resistant Pseudomonas aeruginosa...
10.
den Hollander J, Knudsen J, Mouton J, Fuursted K, Frimodt-Moller N, Verbrugh H, et al.
Antimicrob Agents Chemother
. 1998 Apr;
42(2):377-82.
PMID: 9527789
In this study, we determined the efficacy of various dosing regimens for erythromycin and azithromycin against four pneumococci with different susceptibilities to penicillin in an in vitro pharmacokinetic model and...